Mesh Hysteropexy

Pelvic Floor Disorder Network’s SUPeR Trial Reveals Alternative Hysterectomy Procedure May be Safe Just 5 Months After FDA Ban

Sep 18, 2019 | Mesh Hysteropexy, Pelvic Floor Disorder, Uterovaginal Prolapse, Women's Health

Although the US FDA recently banned the sale of kits used to correct a common pelvic floor problem in women called uterovaginal prolapse, a recent novel study called “SUPeR” sponsored by the Pelvic Floor Disorder Network, in partnership with RTI International, and led...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

Pelvic Floor Disorder Network’s SUPeR Trial Reveals Alternative Hysterectomy Procedure May be Safe Just 5 Months After FDA Ban

Pin It on Pinterest